Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXN
11551
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $92.6K | ﹤0.01% |
12,287
+9,426
| +329% | +$73K |
|
11552
Chefs' Warehouse
CHEF
$4.45B
| $92.5K | ﹤0.01% |
+1,876
| New | +$81.7K |
|
11553
CALL
C4 Therapeutics
CCCC
$522M
| $92.5K | ﹤0.01% |
25,700
-59,400
| -70% | -$295K |
|
11554
CALL
Lindblad Expeditions
LIND
$2.2B
| $92.5K | ﹤0.01% |
7,800
-20,100
| -72% | -$230K |
|
|
RAPT
11555
CALL
DELISTED
RAPT Therapeutics
RAPT
| $92.4K | ﹤0.01% |
7,313
+4,113
| +129% | +$52.2K |
|
11556
PUT
Amplify Lithium & Battery Technology ETF
BATT
$124M
| $92.4K | ﹤0.01% |
+10,500
| New | +$98.4K |
|
|
BCYC
11557
PUT
Bicycle Therapeutics
BCYC
$273M
| $92.4K | ﹤0.01% |
6,600
+500
| +8% | +$10.7K |
|
11558
CALL
Lightwave Logic
LWLG
$1.17B
| $92.4K | ﹤0.01% |
44,000
-6,400
| -13% | -$18.3K |
|
|
PHX
11559
DELISTED
PHX Minerals
PHX
| $92.4K | ﹤0.01% |
23,089
+19,989
| +645% | +$73.5K |
|
11560
Zedge
ZDGE
$38.4M
| $92.3K | ﹤0.01% |
34,322
-24,786
| -42% | -$72.1K |
|
|
PNF
11561
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $92.3K | ﹤0.01% |
+12,420
| New | +$98.9K |
|
11562
CALL
Vivid Seats
SEAT
$80.7M
| $92.1K | ﹤0.01% |
995
+940
| +1,709% | +$70.1K |
|
|
BHR
11563
CALL
Braemar Hotels & Resorts
BHR
$139M
| $92.1K | ﹤0.01% |
30,700
+7,700
| +33% | +$24.9K |
|
11564
CALL
Dole
DOLE
$1.26B
| $92.1K | ﹤0.01% |
6,800
+3,900
| +134% | +$59.9K |
|
11565
PUT
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $92.1K | ﹤0.01% |
1,800
-11,100
| -86% | -$591K |
|
11566
CALL
MacroGenics
MGNX
$269M
| $92K | ﹤0.01% |
28,300
-38,100
| -57% | -$137K |
|
11567
PUT
NetSol Technologies
NTWK
$48.3M
| $92K | ﹤0.01% |
35,100
+15,300
| +77% | +$43.9K |
|
|
PFN
11568
PIMCO Income Strategy Fund II
PFN
$698M
| $91.9K | ﹤0.01% |
+12,332
| New | +$92.8K |
|
11569
PUT
Hyliion Holdings
HYLN
$725M
| $91.9K | ﹤0.01% |
35,200
-27,900
| -44% | -$77.6K |
|
11570
PUT
Sotera Health
SHC
$5.39B
| $91.7K | ﹤0.01% |
6,700
-3,600
| -35% | -$52.2K |
|
11571
Exagen
XGN
$161M
| $91.6K | ﹤0.01% |
22,349
-660
| -3% | -$2.38K |
|
11572
CALL
York Water
YORW
$541M
| $91.6K | ﹤0.01% |
2,800
-3,100
| -53% | -$110K |
|
11573
AEye
LIDR
$60.9M
| $91.5K | ﹤0.01% |
+72,085
| New | +$83.2K |
|
|
GLDD
11574
PUT
DELISTED
Great Lakes Dredge & Dock
GLDD
| $91.4K | ﹤0.01% |
8,100
+4,900
| +153% | +$58.6K |
|
|
ZYXI
11575
DELISTED
Zynex
ZYXI
| $91.4K | ﹤0.01% |
11,415
-44,413
| -80% | -$366K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.